Watson Health to Leverage AI-Based CDS Application for Head Trauma, Stroke Identification | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Watson Health to Leverage AI-Based CDS Application for Head Trauma, Stroke Identification

March 20, 2017
by Rajiv Leventhal
| Reprints

IBM Watson Health is collaborating with an artificial intelligence (AI) healthcare startup with the goal to bring a clinical decision support application to imaging experts that will help doctors identify instances of intracranial bleeding as a result of head trauma and stroke.

The Andover, Mass.-based MedyMatch is a company that utilizes cognitive analytics and artificial intelligence with the aim to deliver real-time decision support tools to improve clinical outcomes in acute medical scenarios. Watson Health is now looking to bring MedyMatch’s A.I.-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings to help doctors identify instances of intracranial bleeding as a result of head trauma and stroke.

Initially, IBM Watson Health’s imaging group will distribute the MedyMatch brain bleed detection application globally through its vendor-neutral sales channels. And moving forward, IBM Watson Health and MedyMatch will aim to develop interoperability between MedyMatch’s application and IBM Watson Health imaging’s offerings, according to an announcement on the collaboration.

According to the American Heart Association and American Stroke Association (AHA/ASA), stroke is the fourth leading cause of death and one of the top causes of preventable disability in the U.S Affecting 4 percent of the U.S. adults, it is forecasted that by 2030, there will be approximately 3.4 million stroke victims annually in the U.S., costing the healthcare system $240 billion on an annual basis.

As such, MedyMatch aims to bring cognitive tools into the daily workflow of an emergency department to help physicians assess patients suspected of head trauma or stroke, and rule out the presence of a bleed in the brain. The MedyMatch algorithm uses deep learning, machine vision, patient data, and clinical insights to automatically highlight for a physician regions of interest that could indicate the potential presence of cerebral bleeds, and does so without interrupting how a physician works. 

MedyMatch is currently conducting a clinical trial for its intracranial bleed assessment application and is working towards a PMA Class III approval by the U.S. FDA.

“The implementation of A.I.-based computer aided detection and clinical decision support tools to medicine in general, and to the emergency department, in particular, has the potential to increase the speed, accuracy, and efficiency of patient management – with the potential to ultimately reduce diagnostic errors and improving clinical outcomes,” Michael Lev, M.D., director of emergency radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School, said in a statement.  “MedyMatch is ideally positioned to leverage this technology, and their willingness to collaborate with industry partners reflects their awareness of, and sensitivity to, the complexities of patient assessment in the acute care setting.  The Company’s first algorithms - CT detection of intracranial bleeds - represents the confluence of physician know-how and artificial intelligence clinical support.”

Gene Saragnese, chairman and CEO of MedyMatch, noted, ““Engaging closely with IBM allows for a near-zero footprint implementation at a customer location delivering ‘A.I. to the bedside’ where I believe the future of healthcare lies.”

Get the latest information on Healthcare Analytics and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Health Sciences South Carolina Wins ‘Best in Show’ at FHIR Applications Roundtable

At the HL7 FHIR Applications Roundtable held in New Orleans in December, Health Sciences South Carolina (HSSC) was voted Best in Show for its clinical data repository for South Carolina hospitals.

2018 Most Influential Women in Health IT Awardees Announced

Four healthcare IT leaders—Ann O’Brien, R.N., Judy Murphy, R.N., Jessica Kahn and Vice Admiral Raquel C. Bono—have been named as the 2018 awardees of HIMSS’ Most Influential Women in Health IT.

Reports: DoD-Cerner EHR Rollout Postponed for 8 Weeks

The Department of Defense (DoD) and Cerner are suspending their MHS Genesis electronic health record (EHR) modernization project for eight weeks, according to multiple media reports.

Change Healthcare Announces Availability of Enterprise-Scale Blockchain Solution

Executives from Nashville-based Change Healthcare have announced that its Intelligent Healthcare Network with blockchain is now available featuring claims management transparency, attesting that it is the first enterprise-scale blockchain in healthcare.

Health IT Experts Join Health Catalyst Team

Salt Lake City-based healthcare data analytics company Health Catalyst has added three health IT and quality heavyweights as strategic advisors.

Rock Health: Digital Health Venture Funding Reached $5.8B in 2017

Digital health venture funding in 2017 approached $6 billion and had the most mega deals ($100 million+) to date, according to a year-end report from San Francisco-based Rock Health.